Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liza Lindenberg

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
IEEE Access : Practical Innovations, Open Solutions|November 4, 2021
Deep Learning Based Staging of Bone Lesions From Computed Tomography ScansSamira Masoudi, Sherif Mehralivand, Stephanie A Harmon, et al.
Computers in Biology and Medicine|March 24, 2025
Development and validation of pan-cancer lesion segmentation AI-model for whole-body 18F-FDG PET/CT in diverse clinical cohortsFahmida Haque, Alex Chen, Nathan Lay, et al.
Clinical Nuclear Medicine|April 23, 2024
Reducing False-Positives Due to Urinary Stagnation in the Prostatic Urethra on 18 F-DCFPyL PSMA PET/CT With MRIDavid G Gelikman, Esther Mena, Liza Lindenberg, et al.
Oncotarget|May 7, 2024
Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GANKevin C Ma, Esther Mena, Liza Lindenberg, et al.
Frontiers in Endocrinology|October 27, 2023
Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [<sup>177</sup>Lu]Lu-DOTA-TATE therapySriram Gubbi, Mohammad Al-Jundi, Sungyoung Auh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 16, 2019
<sup>18</sup>F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumabIlhan Lim, Maria Liza Lindenberg, Esther Mena, et al.
Oncotarget|February 1, 2019
A comparison of prostate cancer bone metastases on <sup>18</sup>F-Sodium Fluoride and Prostate Specific Membrane Antigen (<sup>18</sup>F-PSMA) PET/CT: Discordant uptake in the same lesionStephanie A Harmon, Esther Mena, Joanna H Shih, et al.
European Urology Oncology|October 20, 2023
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with EnzalutamideShruti U Gandhy, Fatima H Karzai, Marijo Bilusic, et al.
Plos One|November 11, 2022
Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinomaEsther Mena, Joanna Shih, Joon-Yong Chung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2018
A Prospective Comparison of <sup>18</sup>F-Sodium Fluoride PET/CT and PSMA-Targeted <sup>18</sup>F-DCFBC PET/CT in Metastatic Prostate CancerStephanie A Harmon, Ethan Bergvall, Esther Mena, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
IEEE Access : Practical Innovations, Open Solutions|November 4, 2021
Deep Learning Based Staging of Bone Lesions From Computed Tomography ScansSamira Masoudi, Sherif Mehralivand, Stephanie A Harmon, et al.
Computers in Biology and Medicine|March 24, 2025
Development and validation of pan-cancer lesion segmentation AI-model for whole-body 18F-FDG PET/CT in diverse clinical cohortsFahmida Haque, Alex Chen, Nathan Lay, et al.
Clinical Nuclear Medicine|April 23, 2024
Reducing False-Positives Due to Urinary Stagnation in the Prostatic Urethra on 18 F-DCFPyL PSMA PET/CT With MRIDavid G Gelikman, Esther Mena, Liza Lindenberg, et al.
Oncotarget|May 7, 2024
Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GANKevin C Ma, Esther Mena, Liza Lindenberg, et al.
Frontiers in Endocrinology|October 27, 2023
Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [<sup>177</sup>Lu]Lu-DOTA-TATE therapySriram Gubbi, Mohammad Al-Jundi, Sungyoung Auh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 16, 2019
<sup>18</sup>F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumabIlhan Lim, Maria Liza Lindenberg, Esther Mena, et al.
Oncotarget|February 1, 2019
A comparison of prostate cancer bone metastases on <sup>18</sup>F-Sodium Fluoride and Prostate Specific Membrane Antigen (<sup>18</sup>F-PSMA) PET/CT: Discordant uptake in the same lesionStephanie A Harmon, Esther Mena, Joanna H Shih, et al.
European Urology Oncology|October 20, 2023
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with EnzalutamideShruti U Gandhy, Fatima H Karzai, Marijo Bilusic, et al.
Plos One|November 11, 2022
Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinomaEsther Mena, Joanna Shih, Joon-Yong Chung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2018
A Prospective Comparison of <sup>18</sup>F-Sodium Fluoride PET/CT and PSMA-Targeted <sup>18</sup>F-DCFBC PET/CT in Metastatic Prostate CancerStephanie A Harmon, Ethan Bergvall, Esther Mena, et al.
Pageof 9